Ronald Buckanovich, MD, Oncology, Pittsburgh, PA, Michigan Medicine

RonaldJBuckanovichMD

Oncology Pittsburgh, PA

Hematologic Oncology

Physician

Dr. Buckanovich is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Buckanovich's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology/Oncology, 2001 - 2004
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
  • Weill Cornell Medical College of Cornell University
    Weill Cornell Medical College of Cornell UniversityClass of 1998

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2006 - 2019
  • PA State Medical License
    PA State Medical License 1999 - 2022
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Elected Member The American Society for Clinical Investigation, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Changing the Perspective for ""Successful"" Maintenance Therapy 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

  • Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian Cancer
    Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian CancerOctober 29, 2019 21:33
  • Targeting Stem-like Cells Could Prevent Ovarian Cancer Recurrence
    Targeting Stem-like Cells Could Prevent Ovarian Cancer RecurrenceMarch 12, 2019 17:49
  • Gynecology | U P D a T E S I N |
    Gynecology | U P D a T E S I N |March 10, 2018 10:37
  • Join now to see all

Grant Support

  • Targeting Ovarian Tumor Associated Myeloid Cells With Nanoparticles TherapeuticsNational Cancer Institute2012
  • Using Embryonic Stem Cells To Re-Create A Human Tumor Microenvironment To DevelopOffice Of The Director, National Institutes Of Health2008

Hospital Affiliations